ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evotec, a German drug discovery services firm, will open a compound management services facility in Branford, Conn. The firm currently operates a similar facility in South San Francisco that it acquired from Galapagos for $18 million in 2011. The Connecticut facility will enable Evotec to better compete for East Coast compound management business, according to Scott Snyder, the firm’s head of compound management. The facility will open in the third quarter.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter